Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of Ketoconazole Cream 2% in Tinea Pedis
NCT04203342Phase 3Completed
- Sponsor
- Douglas Pharmaceuticals
- Start
- Dec 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Ketoconazole Cream in tinea pedis, sponsored by Douglas Pharmaceuticals. Started Dec 2019; status: completed.
02
Drugs
Ketoconazole Cream
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT04203342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203342.